Shirin Geravandi
SARS-CoV-2 and pancreas: a potential pathological interaction?
Geravandi, Shirin; Mahmoudi-aznaveh, Azam; Azizi, Zahra; Maedler, Kathrin; Ardestani, Amin
Authors
Azam Mahmoudi-aznaveh
Zahra Azizi
Kathrin Maedler
Dr Amin Ardestani A.Ardestani@hull.ac.uk
Senior Lecturer
Abstract
The widespread extrapulmonary complications of coronavirus disease 2019 (COVID-19) have gained momentum; the pancreas is another major target for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we take a closer look into potential pathological interactions. We provide an overview of the current knowledge and understanding of SARS-CoV-2 infection of the pancreas with a special focus on pancreatic islets and propose direct, indirect, and systemic mechanisms for pancreas injury as result of the COVID-19–diabetes fatal bidirectional relationship.
Citation
Geravandi, S., Mahmoudi-aznaveh, A., Azizi, Z., Maedler, K., & Ardestani, A. (2021). SARS-CoV-2 and pancreas: a potential pathological interaction?. Trends in Endocrinology & Metabolism, 32(11), 842-845. https://doi.org/10.1016/j.tem.2021.07.004
Journal Article Type | Short Survey |
---|---|
Acceptance Date | Jul 19, 2021 |
Online Publication Date | Jul 24, 2021 |
Publication Date | Nov 1, 2021 |
Deposit Date | Jan 4, 2024 |
Publicly Available Date | Feb 7, 2024 |
Journal | Trends in Endocrinology and Metabolism |
Print ISSN | 1043-2760 |
Electronic ISSN | 1879-3061 |
Publisher | Cell Press |
Peer Reviewed | Peer Reviewed |
Volume | 32 |
Issue | 11 |
Pages | 842-845 |
DOI | https://doi.org/10.1016/j.tem.2021.07.004 |
Keywords | COVID-19; SARS-CoV-2; Islets; β-cell; Pancreas; Inflammation; Diabetes; ACE2; Insulin |
Public URL | https://hull-repository.worktribe.com/output/4461517 |
Files
Accepted manuscript
(290 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
© 2021. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Abnormal acinar–β-cell crosstalk in type 2 diabetes
(2023)
Journal Article